Yaping Wang

Yaping Wang

National Center for Toxicological Research - - / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 4851434
-
person_outline Yaping Wang's MOST POPULAR ARTICLES
1-) FDA approval summary: nivolumab for the treatment of relapsed or progressive classical Hodgkin lymphomaYL Kasamon, RA de Claro, Y Wang, YL Shen, AT Farrell, R PazdurThe oncologist 22 (5), 585-591, 20171272017
2-) FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 MutationED Pulte, KJ Norsworthy, Y Wang, Q Xu, H Qosa, R Gudi, D Przepiorka, ...Clinical Cancer Research 27 (13), 3515-3521, 2021382021
3-) Association Study of G Protein‐Coupled Receptor Kinase 4 Gene Variants with Essential Hypertension in Northern Han ChineseY Wang, B Li, W Zhao, P Liu, Q Zhao, S Chen, H Li, D GuAnnals of human genetics 70 (6), 778-783, 2006372006
4-) Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma …G Lu, R Muddasani, Y Wang, RZ Orlowski, M Zhao, S Chen, IC Glitza, ...Arch Pathol Lab Med 137 (5), 625-631, 2013302013
5-) Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han populationW Zhao, Y Wang, L Wang, X Lu, W Yang, J Huang, S Chen, D GuJournal of hypertension 27 (3), 484-490, 2009232009